布地奈德联合氯雷他定治疗过敏性鼻炎的临床疗效

打开文本图片集

【摘要】目的：探讨布地奈德联合氯雷他定治疗过敏性鼻炎的临床疗效。方法：将2020年1月—2022年12月在本院治疗的84例过敏性鼻炎患者随机分为两组，对照组单用氯雷他定，观察组应用布地奈德联合氯雷他定，对比两组临床疗效、症状评分及生活质量。结果：观察组治疗总有效率为95.24%，明显高于对照组的73.81%，差异有统计学意义（P

【关键词】过敏性鼻炎；布地奈德；氯雷他定；临床疗效

The clinical efficacy of budesonide and loratadine in treating allergic rhinitis

LIN Xinran， LU Lingjuan

Otolaryngology， Head and Neck Surgery，Guangxi International Zhuang Medicine Hospital， Nanning， Guangxi 530001， China

【Abstract】Objective：To investigate the clinical efficacy of budesonide combined with loratadine in the treatment of allergic rhinitis. Methods：84 patients with allergic rhinitis treated in our hospital from January 2020 to December 2022 were randomly divided into two groups.The control group received loratadine alone，and the observation group received budesonide combined with loratadine.The clinical efficacy，symptom scores and quality of life between the groups were compared.Results：The total effective rate of the observation group was 95.24%，which was significantly higher than 73.81% of the control group （P

【Key Words】Allergic rhinitis； Budesonide； Loratadine； Clinical effect

过敏性鼻炎（allergic rhinitis，AR）又称变应性鼻炎，在临床的发病率达19%～23.9%，容易与感冒、鼻窦炎等疾病相混淆，常发生误诊或漏诊[1]。（剩余4192字）